Moreover, after comparing the feline mutations with the genomic human her2 ECD sequence, and searching in the referred databases, the mutations found were never reported as inducing resistance to anti-HER2 immunotherapy in breast cancer patients. The gene discussed is ERBB2; the disease is breast cancer.